Quick Hits: FDA Says Zantac Doesn’t Form Carcinogens in Patients

The Food and Drug Administration’s tests indicate that the popular heartburn drug does not cause carcinogens to form in users.

A recent NBC News article discussed the latest in its investigation into possible contaminants found in the popular heartburn drug Zantac. Tests conducted by the FDA found that the drug does not cause carcinogens to form in patients. The director of the FDA’s Center for Drug Evaluation and Research noted that the levels of NDMA are equivalent to what you might be exposed to while eating common foods like grilled or smoked meats. However, some versions of ranitidine (the generic form of Zantac) contained as much as nine times the acceptable limit for NDMA.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report